Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET)
NCT01994733
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
104
Enrollment
OTHER
Sponsor class
Conditions
End-stage Renal Disease
Interventions
DRUG:
Calcium carbonate ( Intensive phosphate control)
DRUG:
Calcium carbonate (Liberalized phosphate control)
Sponsor
Unity Health Toronto
Collaborators
[object Object]